Total Funding
12
Total FundingSeries C raised
Growth Score
pts
Heat Score
-7 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
See more interactive data and historical milestones on desktop for the best experience
2770134
Trophos is a clinical stage pharmaceutical company developing innovative therapeutics for indications with under-served needs in neurology
Rebecca Pruss: Chief Science Officer
About the Company
Trophos is a clinical stage pharmaceutical company developing innovative therapeutics for indications with under-served needs in neurology and cardiology.
Trophos is a fully integrated clinical stage company with a pipeline of original molecules in development for the motoneuron diseases amyotrophic lateral sclerosis (ALS or Lou Gehrig's
disease) and spinal muscular atrophy (SMA), chemotherapy-induced peripheral neuropathy, cardiac ischemia-reperfusion injury and other neurological conditions.
